AbbVie Inc. (ABBV)
NYSE: ABBV · Real-Time Price · USD
264.34
-0.78 (-0.29%)
At close: Sep 25, 2026, 4:00 PM EDT
265.20
+0.86 (0.33%)
After-hours: Sep 25, 2026, 7:59 PM EDT
AbbVie Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 25, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 467,120 | 403,830 | 314,021 | 273,605 | 285,707 | 239,371 | |
Market Cap Growth | 20.20% | 28.60% | 14.77% | -4.24% | 19.36% | 26.54% |
Enterprise Value | 531,436 | 467,051 | 378,098 | 321,532 | 343,858 | 307,886 |
Last Close Price | 264.34 | 223.21 | 167.73 | 141.12 | 141.45 | 114.07 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 25, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 74.68 | 96.47 | 74.10 | 56.77 | 24.25 | 20.87 |
Forward PE | 17.42 | 16.57 | 14.81 | 13.96 | 12.72 | 10.04 |
PS Ratio | 7.25 | 6.60 | 5.57 | 5.04 | 4.92 | 4.26 |
PB Ratio | - | -125.10 | 93.35 | 26.32 | 16.53 | 15.51 |
P/FCF Ratio | 25.65 | 22.67 | 17.61 | 12.40 | 11.78 | 10.89 |
P/OCF Ratio | 23.95 | 21.22 | 16.70 | 11.98 | 11.45 | 10.51 |
PEG Ratio | 1.29 | 1.09 | 1.68 | 58.43 | 93.44 | 2.03 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 25, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 8.25 | 7.64 | 6.71 | 5.92 | 5.92 | 5.48 |
EV/EBITDA Ratio | 17.28 | 15.97 | 14.65 | 11.95 | 11.98 | 10.89 |
EV/EBIT Ratio | 23.21 | 22.12 | 21.70 | 17.65 | 17.00 | 15.58 |
EV/FCF Ratio | 29.18 | 26.22 | 21.20 | 14.57 | 14.18 | 14.00 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 25, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | -12.04 | -21.19 | 20.29 | 5.83 | 3.74 | 5.03 |
Debt / EBITDA Ratio | 2.28 | 2.31 | 2.61 | 2.23 | 2.22 | 2.71 |
Debt / FCF Ratio | 3.89 | 3.84 | 3.83 | 2.75 | 2.66 | 3.53 |
Net Debt / Equity Ratio | -10.92 | -19.56 | 18.64 | 4.59 | 3.20 | 4.39 |
Net Debt / EBITDA Ratio | 2.09 | 2.16 | 2.43 | 1.78 | 1.93 | 2.40 |
Net Debt / FCF Ratio | 3.53 | 3.54 | 3.52 | 2.17 | 2.28 | 3.08 |
Asset Turnover | 0.47 | 0.46 | 0.42 | 0.40 | 0.41 | 0.38 |
Inventory Turnover | 3.47 | 3.80 | 4.03 | 4.38 | 4.93 | 5.38 |
Quick Ratio | 0.49 | 0.41 | 0.43 | 0.63 | 0.69 | 0.56 |
Current Ratio | 0.81 | 0.67 | 0.66 | 0.87 | 0.96 | 0.79 |
Return on Equity (ROE) | - | 6225.00% | 62.29% | 35.20% | 72.40% | 80.95% |
Return on Assets (ROA) | 10.51% | 9.81% | 8.07% | 8.32% | 8.86% | 8.31% |
Return on Invested Capital (ROIC) | 17.70% | 17.29% | 28.05% | 21.71% | 22.82% | 20.09% |
Return on Capital Employed (ROCE) | 24.50% | 23.30% | 18.10% | 18.80% | 18.50% | 17.70% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 25, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 1.34% | 1.05% | 1.36% | 1.78% | 4.14% | 4.82% |
FCF Yield | 3.90% | 4.41% | 5.68% | 8.06% | 8.49% | 9.19% |
Dividend Yield | 2.62% | 2.98% | 3.75% | 4.25% | 4.04% | 4.66% |
Payout Ratio | 195.50% | 275.84% | 257.71% | 216.72% | 84.85% | 80.24% |
Buyback Yield / Dilution | -0.03% | - | -0.06% | 0.28% | -0.06% | -6.22% |
Total Shareholder Return | 2.59% | 2.98% | 3.69% | 4.53% | 3.98% | -1.56% |